Scholar Rock Holding buy Wolfe Research
Start price
15:39
/
50%
€32.80
Target price
18.11.26
€36.23
Performance (%)
4.88%
Price
22:26
€34.40
Summary
This prediction is currently active. With a performance of 4.88%, the BUY prediction by Wolfe_Research for Scholar Rock Holding is trending in the right direction. This prediction currently runs until 18.11.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | 4.88% |
| iShares Core DAX® | -2.597% |
| iShares Nasdaq 100 | -3.356% |
| iShares Nikkei 225® | -4.112% |
| iShares S&P 500 | -2.520% |
Comments by Wolfe_Research for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
Ratings data for SRRK provided by MarketBeat